|
EIF2AK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.33709999999988E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.62539999995592E-06 |
| Normal-vs-Stage2 |
4.248200E-01 |
| Normal-vs-Stage3 |
3.605200E-04 |
| Normal-vs-Stage4 |
2.040200E-02 |
| Stage1-vs-Stage2 |
1.498500E-03 |
| Stage1-vs-Stage3 |
8.985400E-01 |
| Stage1-vs-Stage4 |
2.293800E-01 |
| Stage2-vs-Stage3 |
1.437690E-02 |
| Stage2-vs-Stage4 |
1.689150E-01 |
| Stage3-vs-Stage4 |
3.785400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.428520E-04 |
| Normal-vs-AfricanAmerican |
2.533900E-02 |
| Normal-vs-Asian |
1.12900000004412E-06 |
| Caucasian-vs-AfricanAmerican |
8.310400E-01 |
| Caucasian-vs-Asian |
3.220300E-02 |
| AfricanAmerican-vs-Asian |
1.813450E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.785200E-04 |
| Normal-vs-Female |
1.646900E-04 |
| Male-vs-Female |
8.945200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.04740000001136E-06 |
| Normal-vs-Age(41-60Yrs) |
1.038660E-04 |
| Normal-vs-Age(61-80Yrs) |
5.484500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.746830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.041400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.509700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.215600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.003190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.274200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.717400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.027400E-01 |
| Classical-VS-Follicular |
3.674400E-01 |
| Classical-VS-Other |
1.580850E-01 |
| Classical-VS-Normal |
1.997980E-04 |
| Tall-VS-Follicular |
4.683800E-01 |
| Tall-VS-Other |
9.584000E-02 |
| Tall-VS-Normal |
3.199700E-03 |
| Follicular-VS-Other |
1.339790E-01 |
| Follicular-VS-Normal |
1.841900E-02 |
| Other-VS-Normal |
5.538200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.357040E-03 |
| Normal-vs-N1 |
2.397300E-04 |
| N0-vs-N1 |
1.501030E-01 |
|
|
